Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10428319 Engineered Cas9 nucleases

Patent 10428319 was granted and assigned to Editas Medicine on October, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12110545 Methods of assessing nuclease cleavage
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+121 characters)
Article

Patent abstract

The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Barrett Ethan Steinberg0
Derek Cerchione0
Edits on 2 Aug, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Aug, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11713455 Enhanced selection of efficient targeted genome manipulating agents
0
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=104283190
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 22 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Editas Medicine
Editas Medicine
0
Current Assignee
Editas Medicine
Editas Medicine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104283190
Date of Patent
October 1, 2019
0
Patent Application Number
160039670
Date Filed
June 8, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=104283190
Patent Citations Received
‌
US Patent 11499151 Methods and systems for analyzing guide RNA molecules
0
Patent Primary Examiner
‌
Robert B Mondesi
0
Edits on 16 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11499151 Methods and systems for analyzing guide RNA molecules
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10428319
Edits on 29 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10428319 Engineered Cas9 nucleases

Infobox
Is a
Patent
Patent
Patent applicant
Editas Medicine
Editas Medicine
Current assignee
Editas Medicine
Editas Medicine
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10428319
Date of patent
October 1, 2019
Patent application number
16003967
Date Filed
June 8, 2018
Patent primary examiner
‌
Robert B Mondesi

Find more entities like US Patent 10428319 Engineered Cas9 nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.